

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : S-Equol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable
A Nutritional Supplement on Vasomotor Symptoms in Women
Details : S-equol is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Menopause.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 18, 2020
Lead Product(s) : S-Equol
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Biofortis Mérieux Nutriscience
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : S-Equol
Therapeutic Area : Neurology
Study Phase : Phase I/ Phase II
Sponsor : Ausio Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
S-Equol in Alzheimer's Disease 2 Trial
Details : S-equol is a Dietary Supplement drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
April 04, 2017
Lead Product(s) : S-Equol
Therapeutic Area : Neurology
Highest Development Status : Phase I/ Phase II
Sponsor : Ausio Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable

S-Equol in Alzheimer's Disease (SEAD) Trial
Details : AUS-131 is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Alzheimer Disease.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
May 20, 2014
